Cath lab directors and EP lab managers occupy an unusual seat in medtech. They are part operational leader and part clinical expert, running the cardiac catheterization and electrophysiology labs where some of the highest-cost consumables in the hospital move through some of the most schedule-sensitive procedures. They are not the cardiologist choosing a therapy, but they are far more than a purchasing clerk. They manage throughput, inventory, physician preference, radiation safety, and the capital equipment the lab runs on. Marketing that treats them as either a pure operations buyer or a clinical decision-maker misses the hybrid reality of the role.

At Buzzbox Media in Nashville, we work with medical device companies selling into cardiology and the cath and EP labs. This guide explains how to market medical devices to cath lab directors: who they are as buyers, what they care about, how they evaluate a device, the channels and conferences that reach them, and the mistakes that cost device companies credibility with this audience.

Who the cath lab director buyer is

The cath lab director, or EP lab manager, runs the day-to-day operation of the cardiac cath lab and the electrophysiology lab. Many come from a clinical background as cardiovascular nurses or technologists, so they understand the procedures intimately, but their role is operational leadership. They own the lab's schedule and throughput, its inventory of high-cost consumables, its radiation safety program, and its capital equipment. Their day runs on case volume, room utilization, inventory value, and the constant balancing of physician preferences against budget.

This is a distinct buyer from the cardiologist. The interventional cardiologist or electrophysiologist is the clinical champion, the one who wants a specific device because of what it does in the procedure. The cath lab director is the one who has to stock it, manage its cost, fit it into the inventory system, and keep the lab running smoothly around it. A device often needs both: the physician who wants it and the director who can make it work operationally. Winning one without the other leaves the decision incomplete.

Inventory economics define this role in a way they do not for most operational buyers. Cath and EP labs carry enormous inventory value in stents, catheters, leads, mapping and ablation consumables, and more, much of it physician-preference-sensitive and expensive to hold. The director is constantly managing the tension between giving physicians the products they prefer and controlling the cost and complexity of the inventory. A device that adds another expensive preference item, without a clear operational or clinical case, meets a director who is already fighting inventory sprawl.

What cath lab directors care about

Throughput and utilization. The lab's value is measured in cases done and rooms used efficiently. A device that streamlines a procedure, reduces setup, or shortens room time speaks the director's language. One that slows the lab or complicates the flow has to justify the cost in operational terms.

Inventory and consumable economics. High-cost consumables dominate the lab's budget. Directors watch inventory value, expiration waste, and the cost per case closely. A device that helps control consumable cost, reduces waste, or consolidates SKUs is more attractive than one that expands an already sprawling, expensive inventory.

Physician preference management. The director lives at the intersection of what physicians want and what the budget allows. A device that a physician strongly prefers still has to be managed operationally. Vendors who help the director reconcile physician preference with cost and standardization make the director's job easier, and earn goodwill.

Radiation safety. Cath and EP labs are radiation environments, and the director owns the safety program for staff and patients. A device that supports dose reduction, or that fits a safe workflow, addresses a responsibility the director cannot compromise on.

Capital equipment and reliability. The lab runs on imaging systems, mapping systems, and other capital equipment, and downtime is costly. Directors weigh how a device or platform fits their existing capital, what support it carries, and how reliably it performs. Dependable supply and responsive service are part of the product story.

How cath lab directors evaluate a device

Cath lab directors evaluate a device on both operational and clinical terms, because their role spans both, and they evaluate it alongside the physicians and the value analysis process rather than alone. They want to understand what a device does to case flow, to inventory, to cost per case, and to radiation safety, and they want that answered in the operational language of the lab, not just in clinical claims. A vendor who speaks only to the physician's clinical interest leaves the director's questions unanswered.

Trials and evaluations matter, and the director judges them through the lab's realities. They watch how a device stocks and reprocesses, how it holds up across a full schedule, whether it introduces waste or expiration risk, and whether it fits the imaging and mapping systems already in place. A pilot that runs cleanly operationally, and that the physicians are satisfied with clinically, builds the director's confidence in a way a data sheet cannot.

Because the director works inside a committee and preference-management process, presentation matters. The director often has to reconcile a physician's clinical enthusiasm for a preference item with the cost scrutiny of value analysis and their own inventory reality. A vendor who equips all sides, clinical evidence for the physician champion, a cost and inventory story for value analysis, and an operational and safety fit story for the director, makes adoption far more likely than one that only courts the physician.

Channels that reach cath lab directors

Interventional cardiology and EP conferences. Cath lab directors and their teams attend the major cardiovascular meetings alongside the physicians. See the interventional cardiology events in the Buzzbox Media conference database at https://www.buzzboxmedia.com/conferences/specialty/interventional-cardiology/ to reach the cath lab audience, and the broader cardiology events at https://www.buzzboxmedia.com/conferences/specialty/cardiology/ for the wider cardiovascular community, including the electrophysiology and imaging worlds that shape lab decisions.

Physician champion relationships. Because so many cath lab decisions pair a physician champion with an operational director, relationships with interventional cardiologists and electrophysiologists are a channel to the lab in themselves. A physician who wants a device and a director who can operationalize it are a powerful combination, and vendors who nurture both move decisions.

Value analysis and inventory engagement. Cath lab directors work closely with value analysis and supply chain on the lab's expensive inventory. Reaching them often means engaging the cost and inventory conversation directly, with the operational materials the director needs, not just the clinical pitch.

Digital and search. Cath and EP lab leaders research devices, workflow, inventory, and safety questions online. Content that speaks to operational and safety concerns, throughput, consumable cost, radiation safety, and capital fit, reaches them during evaluation. Pair this with focused healthcare SEO so your content is found when directors search.

Professional publications and associations. Cardiovascular nursing, cath lab, and EP professional publications reach this audience through channels they read and trust.

Common mistakes when marketing to cath lab directors

Confusing the director with the cardiologist. The physician is the clinical champion; the director runs the lab. A pitch aimed only at the clinical decision-maker leaves the operational buyer, and their questions about cost, inventory, and workflow, unaddressed.

Ignoring inventory economics. Cath and EP labs carry enormous, expensive inventory. A device pitched without a cost, waste, or SKU-consolidation story meets a director already fighting inventory sprawl.

Marketing only the clinical benefit. The director's role is operational as well as clinical. A pitch built entirely around procedure outcomes leaves throughput, inventory, and safety unanswered.

Overlooking radiation safety. The director owns the lab's radiation safety program. A device that ignores dose or safe workflow misses a responsibility the director cannot compromise on.

Underselling reliability and support. In a capital-intensive lab, downtime and unreliable supply are operational failures the director answers for. Vague promises undermine confidence.

Equipping only the physician. Winning the physician champion and leaving the director and value analysis without their own case is a common way a preference item stalls. Equip every seat at the table.